Dr. Steven Benjamin Albright, MD

Dr. Albright practices at Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas.

Dr. Albright's NPI, 1013154590, was assigned on January 20, 2009. Dr. Albright graduated from UT Southwestern Medical Center in 2008. Dr. Albright holds Texas license P8110.

Dr. Albright's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD, at 6550 Fannin St, Houston, TX 77030.

Dr. Albright's primary practice is Texas Children's Hospital - Mfm the Methodist Hospital - HOPD in Houston, Texas. Dr. Albright is also affiliated with Houston Methodist The Woodlands Hospital. The medical group on file is Houston Methodist Institute for Reconstructive Surgery. Dmand AI also links Dr. Albright to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albright practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Albright's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Albright is board certified in plastic surgery by the American Board of Plastic Surgery. Dr. Albright is licensed in Texas.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Albright treats.

CMS data shows 69 Medicare services from Dr. Albright across 3 procedure codes in 2024, for 47 Medicare patients. Medicare paid $4,298 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Albright in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high cholesterol, and 72% have cancer. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Albright's median patient age at 56, with 94% women.

In 2024, Dr. Albright wrote 158 Medicare Part D claims for 37 patients. 99% of them were for generic drugs. CMS names the drug for 120 of them, across 4 drugs with 11 or more claims each, at $1,065 in total drug cost. In 2023, CMS named 84 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Albright for performance year 2024, reported as part of a group. Dr. Albright accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of mastectomy by Dr. Albright, more than 85% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Albright, published from 2011 to 2018. 2014 was the busiest year, with 2. The most frequent topics are Abnormalities, Multiple, Breast Implants and Tissue Expansion Devices. Dr. Albright has published most often in J Craniofac Surg. Dr. Albright's most frequent co-authors are Erik Matthew Wolfswinkel, MD, Larry H. Hollier, MD and Mohin Bhadkamkar, MD.

CMS Open Payments shows 298 general payments to Dr. Albright from 38 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. AxoGen paid the most, $44,507.

Dr. Albright graduated from UT Southwestern Medical Center in 2008. Dr. Albright is a member of AOA and ASPS.

Dr. Albright is in network with 10 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.